Opposite clozapine and ziprasidone effects on the reactivity of plasma albumin SH-group are the consequence of their different binding properties dependent on protein fatty acids content. (25th September 2019)
- Record Type:
- Journal Article
- Title:
- Opposite clozapine and ziprasidone effects on the reactivity of plasma albumin SH-group are the consequence of their different binding properties dependent on protein fatty acids content. (25th September 2019)
- Main Title:
- Opposite clozapine and ziprasidone effects on the reactivity of plasma albumin SH-group are the consequence of their different binding properties dependent on protein fatty acids content
- Authors:
- Uzelac, Tamara N.
Nikolić-Kokić, Aleksandra L.
Spasić, Snežana D.
Mačvanin, Mirjana T.
Nikolić, Milan R.
Mandić, Ljuba M.
Jovanović, Vesna B. - Abstract:
- Abstract: Antipsychotic drugs interfere with the antioxidant defense system provoking complex and often toxicological effects. Here we examined differences in plasma albumin reduced free thiol (SH) group content and its reactivity as a consequence of clozapine (CLZ) and ziprasidone (ZIP) binding. Chronic administration of CLZ reduced, whereas treatment with ZIP increased albumin-SH content in rats. Regardless of the ratio of stearic acid (SA) bound to protein, in vitro binding of ZIP to human serum albumin (HSA) increased both the SH group level and reactivity. In contrast, the effect of CLZ on HSA-SH reactivity was dependent on HSA to SA molar ratio. CLZ binding was accompanied by an increase in HSA-SH reactivity in samples with normal, but a reduction of its reactivity level with higher SA/HSA ratio, compared to drug-free samples. We demonstrate by steady-state fluorescence quenching studies that an increase in SA binding to HSA is associated with a significant reduction of binding constant for both antipsychotics. In addition, this is the first report of quantitative characterization of ZIP binding to HSA. Our findings suggest that albumin-SH content and reactivity is modulated by ZIP towards an increased antioxidant defense capacity in circulation, as opposed to CLZ, which can contribute to the safer, more effective treatment of schizophrenia. Graphical abstract: Image 1 Highlights: Clozapine decreases, while ziprasidone increases free albumin-SH fraction in rats. InAbstract: Antipsychotic drugs interfere with the antioxidant defense system provoking complex and often toxicological effects. Here we examined differences in plasma albumin reduced free thiol (SH) group content and its reactivity as a consequence of clozapine (CLZ) and ziprasidone (ZIP) binding. Chronic administration of CLZ reduced, whereas treatment with ZIP increased albumin-SH content in rats. Regardless of the ratio of stearic acid (SA) bound to protein, in vitro binding of ZIP to human serum albumin (HSA) increased both the SH group level and reactivity. In contrast, the effect of CLZ on HSA-SH reactivity was dependent on HSA to SA molar ratio. CLZ binding was accompanied by an increase in HSA-SH reactivity in samples with normal, but a reduction of its reactivity level with higher SA/HSA ratio, compared to drug-free samples. We demonstrate by steady-state fluorescence quenching studies that an increase in SA binding to HSA is associated with a significant reduction of binding constant for both antipsychotics. In addition, this is the first report of quantitative characterization of ZIP binding to HSA. Our findings suggest that albumin-SH content and reactivity is modulated by ZIP towards an increased antioxidant defense capacity in circulation, as opposed to CLZ, which can contribute to the safer, more effective treatment of schizophrenia. Graphical abstract: Image 1 Highlights: Clozapine decreases, while ziprasidone increases free albumin-SH fraction in rats. In vitro drug effects on HSA-SH level/reactivity depend on stearic acid content. Observed effects are associated with differences in drugs binding to (de)fatted HSA. … (more)
- Is Part Of:
- Chemico-biological interactions. Volume 311(2019)
- Journal:
- Chemico-biological interactions
- Issue:
- Volume 311(2019)
- Issue Display:
- Volume 311, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 311
- Issue:
- 2019
- Issue Sort Value:
- 2019-0311-2019-0000
- Page Start:
- Page End:
- Publication Date:
- 2019-09-25
- Subjects:
- Albumin -- Clozapine -- Ziprasidone -- Thiols
CLZ Clozapine -- ZIP Ziprasidone -- FA(s) Fatty acid(s) -- HSA Human serum albumin -- HSA-SH free thiol in the Cys34 residue of HSA -- SA Stearic acid -- HSA/SA HSA in complex with SA -- HSA/CLZ and HSA/ZIP HSA in complex with CLZ and ZIP, respectively -- DMSO Dimethyl sulfoxide -- DTNB 5, 5′-Dithiobis-(2-nitrobenzoic acid)
Biochemistry -- Periodicals
Toxicological chemistry -- Periodicals
Biochemistry -- Periodicals
Biologie moléculaire -- Périodiques
Biochimie -- Périodiques
Toxicologie biochimique -- Périodiques
572 - Journal URLs:
- http://www.sciencedirect.com/science/journal/00092797 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.cbi.2019.108787 ↗
- Languages:
- English
- ISSNs:
- 0009-2797
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3155.500000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 11647.xml